Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Leonardo Yllel Da Rocha

1PUBLICATIONS

5CO-AUTHORS

Aerospace materials

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 16, 2026

Beyond Genotype: Tomographic Improvement With Elexacaftor Tezacaftor Ivacaftor in Non-F508del Cystic Fibrosis.

Renata Wrobel Folescu Cohen, Patrícia Fernandes Barreto Machado Costa, Katty Anne Carvalho Marins

Pageof 1

Frequent Collaborators

1 joint publications

Renata Wrobel Folescu Cohen

1 joint publications

Patrícia Fernandes Barreto Machado Costa

1 joint publications

Katty Anne Carvalho Marins

1 joint publications

Natalia Dias Barboza

1 joint publications

Tania Wrobel Folescu

Frequent Collaborators

1 joint publications

Renata Wrobel Folescu Cohen

1 joint publications

Patrícia Fernandes Barreto Machado Costa

1 joint publications

Katty Anne Carvalho Marins

1 joint publications

Natalia Dias Barboza

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos